Treating second-relapsed/refractory first-relapsed childhood acute myeloid leukaemia: Successful salvage rather than palliation?
Pietro MerliPublished in: British journal of haematology (2022)
Prognosis of second-relapsed/refractory first-relapsed childhood acute myeloid leukaemia remains poor and there are no clear guidelines on the best treatment approach. The report by White et al. suggests that, while outcomes are still unsatisfactory, there is room to pursue a curative approach rather than palliation. Commentary on: White et al. Clinical outcomes of second relapsed and refractory first relapsed paediatric AML: A retrospective study within the NOPHO-DB SHIP consortium. Br J Haematol 2022;197:755-765.
Keyphrases
- acute myeloid leukemia
- acute lymphoblastic leukemia
- hodgkin lymphoma
- multiple myeloma
- diffuse large b cell lymphoma
- allogeneic hematopoietic stem cell transplantation
- liver failure
- respiratory failure
- emergency department
- bone marrow
- type diabetes
- rectal cancer
- adipose tissue
- metabolic syndrome
- skeletal muscle
- childhood cancer